Potential effect of ethanolic extract of Abutilon indicum (L.) against acetic acid induced ulcerative colitis in albino rats
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20262862Keywords:
Abutilon indicum, Acetic acid, Inflammatory bowel disease, Sulfasalazine, Ulcerative colitisAbstract
Background: Ulcerative colitis (UC) is a chronic, relapsing inflammatory disorder of the colon characterized by mucosal inflammation, ulceration, and disruption of intestinal homeostasis Abutilon indicum (L.), a traditionally used medicinal plant in Ayurvedic and folk medicine, has been reported to possess various pharmacological activities including anti-inflammatory, antioxidant, analgesic, and wound healing effects. However, its potential role in the management of ulcerative colitis remains inadequately explored and requires scientific validation.
Methods: Animals were treated for 11 days in different groups. Group I received normal saline, Group II received distilled water, Group III received sulfasalazine, and Groups IV & V received Abutilon indicum extract at two doses. On day 8, ulcerative colitis was induced in Groups II-V using 4% acetic acid administered rectally. On day 11, animals were anesthetized, blood samples were collected, and colon tissues were preserved for analysis (cytokine study and histopathology).
Results: The study showed that ethanolic extract of Abutilon indicum leaves has significant anti-ulcerative colitis activity against acetic acid-induced colitis. Both doses (250 mg/kg and 500 mg/kg) were effective, but 500 mg/kg showed better results. This effect was confirmed by reduced inflammatory markers (TNF-a, IL-6), decreased colon weight-length ratio, and improved histopathological findings.
Conclusions: The findings suggest that the plant possesses promising anti-colitic potential and may serve as a natural therapeutic candidate for the management of ulcerative colitis. Further studies are warranted to isolate the active constituents, elucidate the underlying molecular mechanisms, and establish its clinical efficacy and safety.
References
World Health Organization. WHO traditional medicine strategy: 2014-2023, 2013. Available at: https://www.who.int/publications/i/item/9789241506096. Accessed 01 January 2026.
Fabricant DS, Farnsworth NR. The value of plants used in traditional medicine for drug discovery. Environment Heal Perspect. 2001;109(Suppl 1):69-75.
Ekor M. The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Frontiers in Pharmacology. 2014;4:177.
Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Crohn's disease. Lancet. 2017;389(10080):1741-55.
Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. The Lancet. 2017;389(10080):1756-70.
Danese S, Fiocchi C. Ulcerative colitis. N Engl J Medi. 2011;365(18):1713-1725.
Bodhankar SL, Vyas CA. Pathophysiology. 6th ed. Pune: Nirali Prakashan; 2008:7-8.
Roy G. Inflammatory bowel disease in India: Past, present and future. W J Gastroenterol. 2016;22(36):8123-36.
Cleveland Clinic. Ulcerative colitis: Symptoms, causes, diagnosis & treatment. Cleveland (OH): Cleveland Clinic; updated 2023. Available at: https://my.clevelandclinic.org/health/diseases/10351-ulcerative-colitis. Accessed 07 June 2026.
Bennett PN, Brown MJ. Clinical Pharmacology. 9th ed. Edinburgh: Churchill Livingstone; 2003:645.
Mahadevan U. Medical treatment of ulcerative colitis. Semi Gastrointest Dis. 2004;15(1):7-19.
Rajathi K, Indumathi T. Anti-ulcer activity of Premna serratifolia against aspirin-induced gastric ulcer model. Int Res J Pharm. 2013;4(6):171-3.
Ram S, Kotecha M, Chaudhary K. Review on Abutilon indicum (Linn.) Sweet (Atibala): An important herb in Ayurveda. Int Res J Ayurveda Yoga. 2021;4(7):114-22.
Krupanidhi AM, Dabadi P, Chandana M, Mythree MV, Pooja HS, Pooja JU, et al. A brief review on pharmacological properties of Abutilon indicum roots. Asian J Pharm Pharmacol. 2022;8(4):121-6.
Saranyaa SV, Dhanalakshmi J. Abutilon indicum: A review on its ethnobotany, phytochemical and pharmacological profile. Kongunadu Res J. 2025;12(2):24-30.
Srivastava SP, Dikshit S, Moharana A, Chaturvedi N, Sharma S, Verma P. Abutilon indicum: bioactive compounds and diverse therapeutic applications. Curr Nutraceut. 2024;5(1):e170124225755.
Gupta A, Singh A, Prasad R. A review on watermelon (Citrullus lanatus) medicinal seeds. J Pharmacog Phytochem. 2018;7(3):2222-5.
Junaid R, Shaikh, Patil MK. Qualitative test for preliminary phytochemical screening: An overview. Int J Chem Stud. 2020;8(2):603-8.
Millar AD, Rampton DS, Chander CL, Claxson AW, Blades S, Coumbe A, et al. Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using the acetic acid-induced colitis model in rats. Brit J Pharmacol. 1996;118(4):996-1002.
Randhawa PK, Singh K, Singh N, Jaggi AS. A review on chemical-induced inflammatory bowel disease models in rodents. Korean J Physiol Pharmacol. 2014;18(4):279-88.
Dashputre NL, Naikwade NS. Recent developments in anti-inflammatory natural products. Medicinal Research Reviews. 2009; 29(5):767-820.
Gautam R, Jachak SM. Effect of polyherbal formulation on experimental models of inflammatory bowel diseases. J Ethnopharmacol. 2004;90(2):196-204.
Wirtz S, Neufert C, Weigmann B, Neurath MF. Chemically induced mouse models of intestinal inflammation. Nature Protocols. 2017;12(7):1295-1309.
Jagtap AG, Niphadkar PV, Phadke AS. Protective effect of herbal agents in experimental colitis. Ind J Pharmacol. 2004;36(3):159-63.